Meta-analysis of Soluble Fiber Consumption on Body Weight, Glycemia, and Insulinemia in Overweight and Obese Adults.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

609 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-01-31

Study Completion Date

2017-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Dietary fiber intake is protective against overweight and obesity; however, a significant fiber gap exists between consumption and recommended intake values. Soluble fiber beneficially impacts metabolism, and supplementation may be a feasible approach to improve body composition and glycemia in overweight and obese individuals. The investigators will evaluate results of randomized controlled trials (RCTs) of soluble fiber supplementation among overweight and obese adults for outcomes related to weight management (e.g. body mass index \[BMI\], body weight, body fat percentage, waist circumference) and glucose and insulin homeostasis (e.g. fasting glucose, homeostasis model assessment of insulin resistance \[HOMA-IR\], fasting insulin) through systematic review and meta-analysis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effects of Dietary Fibre on Glucose Metabolism and Satiety

NCT02093481

Obesity Metabolic Syndrome

COMPLETED EARLY_PHASE1

Effect of Viscous Soluble Fibres on Body Weight

NCT03257449

Overweight and Obesity T2DM (Type 2 Diabetes Mellitus) General Population

UNKNOWN

Effects of Caffeinated and Decaffeinated Coffee on Body Weight and Glucose Tolerance

NCT00305097

Overweight

COMPLETED NA

Over-night Effect of Dietary Fiber on Glucose Metabolism and Satiety

NCT02347293

Obesity Metabolic Syndrome

COMPLETED EARLY_PHASE1

Metabolic Effects of Oral Sodium Butyrate Supplementation on Overweight Individuals

NCT06247020

Glucose Metabolism Disorders Overweight or Obesity

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Soluble Fiber Treatment

Participants receiving soluble fiber.

Soluble Fiber

Intervention Type OTHER

Participants receiving soluble fiber.

Placebo Treatment

Participants receiving placebo.

Placebo

Intervention Type OTHER

Participants receiving placebo.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Soluble Fiber

Participants receiving soluble fiber.

Intervention Type OTHER

Placebo

Participants receiving placebo.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Peer-reviewed randomized controlled trials (RCTs) will be included in the systematic review and meta-analysis if they involve participants who are:

1. Overweight or obese (BMI ≥ 25.0 kg/m2 for U.S. populations and ≥ 23.0 kg/m2 for Asian populations and/or waist circumference ≥ 40 inches (94 cm) in men or ≥ 35 inches (80 cm) in women and/or waist-to-hip ratio ≥ 0.90 in men or ≥ 0.85 in women).
2. Weight stable and not actively trying to lose weight at screening.
3. Without physician-diagnosed chronic conditions at screening (e.g., dyslipidemia, hypertension, type 2 diabetes, and cardiovascular disease).
4. Included studies will be soluble fiber supplementation interventions that are controlled feeding studies or conducted among free-living subjects that provide data for outcomes of interest.

Exclusion Criteria

Studies will be excluded from the systematic review and meta-analysis if they meet any of the following criteria:

1. Studies conducted in animals.
2. Mechanistic research.
3. Human trials involving pregnant women, breastfeeding women, or children.
4. Conference proceedings.
5. Articles not published in English.
6. Studies less than 1 week in duration.
7. Studies that pool outcome measure data for healthy weight and overweight and obese individuals.
8. Studies involving whole food treatments or high fiber profile diets.
9. Weight loss interventions involving other tactics, such as counseling or energy restriction.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No